Keyphrases
Adjuvant Chemotherapy
100%
Patients with Colorectal Cancer
100%
Colorectal Cancer Mortality
100%
Elderly Patients
100%
Young Patients
83%
Comorbidity
83%
Performance Status
50%
Colorectal Cancer
33%
Poor Performance Status
33%
Baseline Characteristics
16%
Oxaliplatin
16%
Chemotherapy
16%
5-fluorouracil (5-FU)
16%
Dose Intensity
16%
Initial Dose
16%
Single-center Study
16%
Primary Colorectal Cancer
16%
Herlev
16%
Capecitabine
16%
Treatment Outcome
16%
Patient Status
16%
In(III)
16%
Overall Survival
16%
Dose Reduction
16%
Stage II-III
16%
Age-related Differences
16%
Denmark
16%
Disease-free Survival
16%
Immunology and Microbiology
Cancer Mortality
100%
Comorbidity
83%
Overall Survival
16%
Drug Dose Reduction
16%
Disease Free Survival
16%